Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 09-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -16,560 | -12,304 | -9,670 | -8,840 |
| Depreciation Amortization | 650 | 422 | 300 | 290 |
| Accounts payable and accrued liabilities | N/A | -700 | N/A | N/A |
| Other Working Capital | -250 | 316 | -420 | -420 |
| Other Operating Activity | 2,890 | 2,878 | 650 | 90 |
| Operating Cash Flow | $-13,270 | $-9,388 | $-9,140 | $-8,880 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,930 | -2,893 | -1,400 | -420 |
| Other Investing Activity | 230 | 850 | -140 | -2,700 |
| Investing Cash Flow | $-2,700 | $-2,043 | $-1,540 | $-3,120 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 1,100 | N/A | N/A |
| Debt Repayment | N/A | -40 | N/A | N/A |
| Common Stock Issued | N/A | 32 | N/A | N/A |
| Other Financing Activity | 11,330 | 931 | 19,620 | 17,930 |
| Financing Cash Flow | $11,330 | $2,023 | $19,620 | $17,930 |
| Beginning Cash Position | 15,210 | 15,217 | 6,270 | 350 |
| End Cash Position | 10,570 | 5,809 | 15,210 | 6,270 |
| Net Cash Flow | $-4,640 | $-9,408 | $8,940 | $5,910 |
| Free Cash Flow | ||||
| Operating Cash Flow | -13,270 | -9,388 | -9,140 | -8,880 |
| Capital Expenditure | N/A | -2,893 | N/A | N/A |
| Free Cash Flow | -13,270 | -12,281 | -9,140 | -8,880 |